Inovalon Stock Forecast, Price & News

Inovalon (NASDAQ:INOV) Frequently Asked Questions

Is Inovalon a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares.
View analyst ratings for Inovalon or view top-rated stocks.

How has Inovalon's stock price been impacted by Coronavirus (COVID-19)?

Inovalon's stock was trading at $17.36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INOV shares have increased by 136.5% and is now trading at $41.06.
View which stocks have been most impacted by COVID-19.

Are investors shorting Inovalon?

Inovalon saw a decrease in short interest in October. As of October 29th, there was short interest totaling 4,500,000 shares, a decrease of 19.2% from the October 14th total of 5,570,000 shares. Based on an average trading volume of 1,110,000 shares, the short-interest ratio is presently 4.1 days. Currently, 6.1% of the shares of the company are sold short.
View Inovalon's Short Interest.

When is Inovalon's next earnings date?

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Inovalon.

How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) posted its quarterly earnings data on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. The technology company had revenue of $190.44 million for the quarter, compared to analyst estimates of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%.
View Inovalon's earnings history.

What price target have analysts set for INOV?

6 equities research analysts have issued 1-year price objectives for Inovalon's shares. Their forecasts range from $23.00 to $41.00. On average, they anticipate Inovalon's stock price to reach $32.67 in the next twelve months. This suggests that the stock has a possible downside of 20.4%.
View analysts' price targets for Inovalon or view top-rated stocks among Wall Street analysts.

Who are Inovalon's key executives?

Inovalon's management team includes the following people:

• Keith R. Dunleavy, Chairman & Chief Executive Officer
• Eron S. Kelly, President
• Jonathan R. Boldt, Chief Financial & Accounting Officer
• Paige C. Kilian, Chief Medical Officer
• Monica Keeneth, Chief Information Security Officer & VP

What is Keith R. Dunleavy's approval rating as Inovalon's CEO?

410 employees have rated Inovalon CEO Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among Inovalon's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Inovalon's key competitors?

Some companies that are related to Inovalon include Bilibili (BILI), RingCentral (RNG), Toast (TOST), GoodRx (GDRX), Clarivate (CLVT), Zendesk (ZEN), Globant (GLOB), Five9 (FIVN), Pegasystems (PEGA), TELUS International (Cda) (TIXT), PagSeguro Digital (PAGS), ironSource (IS), DXC Technology (DXC), Playtika (PLTK) and Zynga (ZNGA).
View all of INOV's competitors.

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (3.28%), Millennium Management LLC (2.05%), ArrowMark Colorado Holdings LLC (1.98%), Citigroup Inc. (1.30%), Morgan Stanley (1.11%) and Neuberger Berman Group LLC (1.00%). Company insiders that own Inovalon stock include Bock Peter De, Jason Capitel, Jonathan R Boldt, Keith R Dunleavy, Mark Pulido, Robert A Wychulis and William J Teuber Jr.
View institutional ownership trends for Inovalon.

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Eaton Vance Management, Invesco Ltd., BlackRock Inc., Neuberger Berman Group LLC, Cowen Prime Advisors LLC, RE Advisers Corp, King Luther Capital Management Corp, and ArrowMark Colorado Holdings LLC. Company insiders that have sold Inovalon company stock in the last year include Jason Capitel, Jonathan R Boldt, and Mark Pulido.
View insider buying and selling activity for Inovalon or view top insider-selling stocks.

Which institutional investors are buying Inovalon stock?

INOV stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citigroup Inc., Morgan Stanley, Alpine Associates Management Inc., TIG Advisors LLC, UBS Group AG, Balyasny Asset Management LLC, and Balyasny Asset Management LLC. Company insiders that have bought Inovalon stock in the last two years include Bock Peter De, Keith R Dunleavy, and William J Teuber Jr.
View insider buying and selling activity for Inovalon or or view top insider-buying stocks.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $41.06.

How much money does Inovalon make?

Inovalon has a market capitalization of $6.37 billion and generates $667.52 million in revenue each year. The technology company earns $22.58 million in net income (profit) each year or $0.34 on an earnings per share basis.

How many employees does Inovalon have?

Inovalon employs 1,836 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is www.inovalon.com.

Where are Inovalon's headquarters?

Inovalon is headquartered at 4321 COLLINGTON ROAD, BOWIE MD, 20716.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at (301) 809-4000, via email at [email protected], or via fax at 301-809-8060.